ArticleCancer2015

A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses.

Przemyslaw Twardowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.